MYC and breast cancer: For example, BCL2 and MYC, well-known oncogenes that inhibit apoptosis and promote cell proliferation, have been reported to undergo m6A-mediated translation, stabilization, or indirect promotion in bladder cancer [46,59], lung cancer [60], breast cancer [61,62], acute myeloid leukemia (AML) [63], and gastric cancer [64,65].